Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2026-06-22 16:37:11 ET · period of report 2026-06-22 · accession 0001902368-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 16:37 | 2026-06-22 | TVTX | Inrig Jula | Chief MEDICAL Off | G - Gift | $0.00 | -468 | 112.8K | -0.4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-22 | G | D | 468 | $0.00 | 112,770 | D | — | — | (F1) This transaction represents a bona fide gift of 468 shares of common stock to a donor-advised fund. The reporting person authorized the gift on June 16, 2026, and the transfer occurred on June 22, 2026. |